摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-1-tert-butyl 4-methyl 2-phenylsuccinate | 1229382-63-1

中文名称
——
中文别名
——
英文名称
(+/-)-1-tert-butyl 4-methyl 2-phenylsuccinate
英文别名
1-Tert-butyl 4-methyl 2-phenylsuccinate;1-O-tert-butyl 4-O-methyl 2-phenylbutanedioate
(+/-)-1-tert-butyl 4-methyl 2-phenylsuccinate化学式
CAS
1229382-63-1
化学式
C15H20O4
mdl
——
分子量
264.321
InChiKey
IIIRARGKFNLWDR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Preparation of Chiral 3-Arylpyrrolidines via the Enantioselective 1,4-Addition of Arylboronic Acids to Fumaric Esters Catalyzed by Rh(I)/Chiral Diene Complexes
    摘要:
    A highly efficient rhodium-catalyzed protocol for the preparation of 2-arylsuccinic esters and 3-arylpyrrolidines of high optical purity has been achieved. In the presence of 1 mol % of a chiral diene/Rh(I) catalyst, asymmetric addition of various arylboronic acids to di-fert-butyl fumarate (3c) provides the corresponding adducts in up to 99% yield and 94 -> 99.5% ee. Excellent enantioselectivities were also observed in the regio- and enantioselective conjugate addition of phenylboronic acid (4a) to compound 3e.
    DOI:
    10.1021/ol300980k
  • 作为产物:
    描述:
    叔-丁基苯乙酸酯溴乙酸甲酯正丁基锂二异丙胺 作用下, 以 四氢呋喃正己烷 为溶剂, 反应 3.75h, 以82%的产率得到(+/-)-1-tert-butyl 4-methyl 2-phenylsuccinate
    参考文献:
    名称:
    Preparation of Chiral 3-Arylpyrrolidines via the Enantioselective 1,4-Addition of Arylboronic Acids to Fumaric Esters Catalyzed by Rh(I)/Chiral Diene Complexes
    摘要:
    A highly efficient rhodium-catalyzed protocol for the preparation of 2-arylsuccinic esters and 3-arylpyrrolidines of high optical purity has been achieved. In the presence of 1 mol % of a chiral diene/Rh(I) catalyst, asymmetric addition of various arylboronic acids to di-fert-butyl fumarate (3c) provides the corresponding adducts in up to 99% yield and 94 -> 99.5% ee. Excellent enantioselectivities were also observed in the regio- and enantioselective conjugate addition of phenylboronic acid (4a) to compound 3e.
    DOI:
    10.1021/ol300980k
点击查看最新优质反应信息

文献信息

  • COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS
    申请人:Hoveyda Hamid
    公开号:US20110230477A1
    公开(公告)日:2011-09-22
    The present invention is directed to novel compounds of formula (I) and their use in treating metabolic diseases.
    本发明涉及式(I)的新化合物及其在治疗代谢性疾病方面的应用。
  • Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
    申请人:Euroscreen S.A.
    公开号:EP2364297A1
    公开(公告)日:2011-09-14
  • [EN] COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS<br/>[FR] COMPOSÉS, COMPOSITION PHARMACEUTIQUE ET MÉTHODES POUR APPLICATION AU TRAITEMENT DE TROUBLES MÉTABOLIQUES
    申请人:EUROSCREEN SA
    公开号:WO2010066682A1
    公开(公告)日:2010-06-17
    The present invention is directed to novel compounds of formula (I) and their use in treating metabolic diseases.
  • [EN] COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING GASTROINTESTINAL DISORDERS<br/>[FR] COMPOSÉS, COMPOSITION PHARMACEUTIQUE ET PROCÉDÉS POUR UTILISATION DANS LE TRAITEMENT DE TROUBLES GASTRO-INTESTINAUX
    申请人:EUROSCREEN SA
    公开号:WO2011076732A1
    公开(公告)日:2011-06-30
    The present invention relates to compounds of formula (I) useful in treating and/or preventing gastrointestinal disorders.
  • [EN] COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING INFLAMMATORY DISEASES<br/>[FR] COMPOSÉS, COMPOSITION PHARMACEUTIQUE ET PROCÉDÉS POUR UTILISATION DANS LE TRAITEMENT DE MALADIES INFLAMMATOIRES
    申请人:EUROSCREEN SA
    公开号:WO2011076734A1
    公开(公告)日:2011-06-30
    The present invention relates to compounds of formula (I) (I) useful in treating and/or preventing inflammatory diseases.
查看更多